Dublin, Jan. 31, 2019 (GLOBE NEWSWIRE) -- The "Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), and End User - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The cell surface markers market is projected to reach USD 769 million by 2023 from USD 520 million in 2018, at a CAGR of 8.1% during the forecast period.
The growth of this market is majorly driven by the high global prevalence of cancer, increasing funding for life sciences research, and growth in stem cell and neurobiology research. On the other hand, factors such as the costly and time-intensive antibody development process may hinder the growth of this market in the coming years. Antibodies segment is expected to grow at the highest CAGR during the forecast period Based on product type, the cell surface markers market is segmented into antibodies and PCR arrays. The antibodies segment is expected to account for a larger share of the market in 2018 as well as grow at a higher CAGR during the forecast period. This can majorly be attributed to the increasing demand for accurate and reliable antibodies by research communities. T cell surface markers segment is expected to account for the largest share of the cell surface markers market, by cell type, during the forecast period Based on cell type, the cell surface markers market is segmented into T cell surface markers, B cell surface markers, NK cell surface markers, monocyte cell surface markers, and other cell types. In 2018, the T cell surface markers segment is expected to account for the largest share of the cell surface markers market. The large share of this segment is attributed to the high and growing use of T cell surface markers in research and diagnostics. North America to dominate the market during the forecast period In 2018, North America is expected to account for the largest share of the cell surface markers market. North America has a well-established pharmaceuticals sector and currently dominates the cell surface markers market due to the increasing demand for the effective diagnosis and treatment of chronic diseases. Also, the adoption rate of cell surface markers for disease diagnostics, majorly for cancer diagnosis, is high in North America. This is one of the major factors supporting the growth of this regional market.
The Asian market, on the other hand, is expected to grow at the highest CAGR during the forecast period. Factors such as government initiatives to boost biotechnology and pharmaceutical industries and increasing life sciences research activities are supporting the growth of the cell surface markers market in Asia.
Topics Covered
1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2 Research Methodology 2.1 Research Design 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3 Executive Summary 4 Premium Insights 4.1 Cell Surface Markers: Market Overview 4.2 Cell Surface Markers Market, By Product 4.3 Cell Surface Markers Market, By Cell Type (2018) 4.4 Cell Surface Markers Market, By Application, 2018 vs 2023 (USD Million) 4.5 Cell Surface Markers Market, By End User, 2018 vs 2023 (USD Million) 4.6 Cell Surface Markers Market: Geographic Growth Opportunities 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Increasing Funding for Life Science Research 5.2.1.2 High Global Prevalence of Cancer 5.2.1.3 Growth in Stem Cell and Neurobiology Research 5.2.2 Restraints 5.2.2.1 Costly and Time-Intensive Antibody Development Process 5.2.3 Opportunities 5.2.3.1 High Growth Opportunities in Emerging Markets 6 Cell Surface Markers Market, By Product 6.1 Introduction 6.2 Antibodies 6.2.1 Antibodies to Dominate the Cell Surface Marker Products Market During the Forecast Period 6.3 PCR Arrays 6.3.1 PCR Array Profiles the Expression of Genes Relevant to Research at the Cell Surface Marker Level 7 Cell Surface Marker Antibodies Market, By Source 7.1 Introduction 7.2 Mice 7.2.1 Mice are the Most Preferred Hosts for Research-Use Cell Surface Antibody Production 7.3 Rats 7.3.1 Rats are the Second-Most-Widely Used Animal Hosts for Monoclonal Antibody Production 7.4 Other Sources 8 Cell Surface Markers Market, By Cell Type 8.1 Introduction 8.2 T Cell Surface Markers 8.2.1 T Cell Surface Markers to Account for the Largest Market Share in 2018 8.3 B Cell Surface Markers 8.3.1 B Cell Surface Markers are Used to Identify B Cells From Heterogeneous Samples 8.4 NK Cell Surface Markers 8.4.1 NK Cell Surface Markers Identify NK Cells at Various Stages of Development 8.5 Monocyte Cell Surface Markers 8.5.1 Monocytes Play A Critical Role in Maintaining Overall Health 8.6 Other Cell Types 9 Cell Surface Markers Market, By Application 9.1 Introduction 9.2 Research Applications 9.2.1 Drug Discovery 9.2.1.1 Cell Surface Markers Play an Important Role in Guiding Decisions in Every Phase of Drug Development 9.2.2 Immunology 9.2.2.1 The Assessment of Cell Surface Antigens Using Cell Surface Markers is an Important Field of Immunological Research 9.2.3 Stem Cell Research 9.2.3.1 Cell Surface Biomarkers are Used to Characterize, Isolate and Analyze Stem Cells 9.2.4 Other Research Applications 9.3 Clinical Applications 9.3.1 Oncology 9.3.1.1 Cell Surface Markers are an Emerging Diagnostic Tool in the Field of Hematological Oncology 9.3.2 Immunodeficiency Diseases 9.3.2.1 Cell Surface Markers are Used for the Detection of HIV Infections 9.3.3 Other Clinical Applications 10 Cell Surface Markers Market, By End User 10.1 Introduction 10.2 Academic & Research Institutes 10.2.1 Academic & Research Institutes are the Largest End Users of the Cell Surface Markers Market 10.3 Hospitals & Clinical Testing Laboratories 10.3.1 Hospitals & Clinical Testing Laboratories Use Cell Surface Markers for the Diagnosis of Various Diseases 10.4 Pharmaceutical & Biotechnology Companies 10.4.1 Patent Expiration of Blockbuster Drugs to Drive the Growth of the Cell Markers Market for This End-User Segment 11 Cell Surface Markers Market, By Region 11.1 Introduction 11.2 North America 11.2.1 US 11.2.1.1 High Prevalence of Chronic Diseases 11.2.1.2 Favorable Funding for Precision Medicine Research Activities 11.2.2 Canada 11.2.2.1 Availability of Research Funding 11.2.2.2 Increasing Prevalence of Cancer 11.3 Europe 11.3.1 Germany 11.3.1.1 Availability of Funding Driving the Number of Research Activities 11.3.1.2 Large-Scale Outsourcing of Clinical Diagnostic Testing By Hospitals to Commercial Service Providers 11.3.2 France 11.3.2.1 Presence of A Large Biotechnology Industry 11.3.2.2 Government Initiatives to Boost Research and Development Activities 11.3.3 UK 11.3.3.1 Government Initiatives to Strengthen Academic Research 11.3.3.2 Increasing Incidence and Prevalence of Chronic and Infectious Diseases 11.3.4 RoE 11.4 Asia 11.5 RoW 12 Competitive Landscape 12.1 Overview 12.2 Market Ranking Analysis 12.3 Competitive Scenario 12.3.1 Partnerships and Agreements (2016-2018) 12.3.2 Product Launches (2016-2018) 12.3.3 Acquisitions (2016-2018) 12.3.4 Expansions (2016-2018) 13 Company Profiles 13.1 Thermo Fisher Scientific 13.2 Becton, Dickinson and Company 13.3 Abcam 13.4 Qiagen N.V. 13.5 F. Hoffman-La Roche 13.6 Bio-Rad Laboratories 13.7 Danaher Corporation 13.8 Genscript 13.9 Biolegend 13.10 Cell Signaling Technology 13.11 Bio-Techne 13.12 Merck KGaA
For more information about this report visit https://www.researchandmarkets.com/research/6..._cell?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Biomarkers
